7OVC | pdb_00007ovc

Structure of the human UFC1 protein in complex with the UBA5 C-terminal UFC1-binding motif.

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D [15N,1H]-TROSY-(H)C(CC)(CO)NH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III HD 700
2	3D [15N,1H]-TROSY-H(C)(CC)(CO)NH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III HD 700
3	3D BEST-[15N,1H]-TROSY-HNCACB	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
4	3D F1-13C/15N-filtered NOESY-[13C,1H]-HSQC	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
5	3D F1-13C/15N-filtered NOESY-[15N,1H]-SOFAST-HMQC	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
6	3D F1-13C/15N-filtered NOESY-[13C,1H]-SOFAST-HMQC (aro)	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
7	3D NOESY-[13C,1H]-SOFAST-HMQC (aro)	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
8	3D NOESY-[13C,1H]-HSQC (aliphatic region)	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
9	3D NOESY-BEST-[15N,1H]-TROSY	1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
10	3D BEST-[15N,1H]-TROSY-HNCA	1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
11	3D BEST-[15N,1H]-TROSY-HNCACB	1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
12	3D F1-13C/15N-filtered NOESY-[13C,1H]-HSQC	1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III 950
13	3D [15N,1H]-TROSY-(H)C(CC)(CO)NH-TOCSY	1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III HD 700
14	3D NOESY [13C,1H]-HSQC	1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE NEO 900
15	3D [15N,1H]-TROSY-H(CC)(CO)NH-TOCSY	1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE II 600
16	3D NOESY-[15N,1H]-SOFAST-HMQC	1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS	95% H2O/5% D2O	100 mM	7.5	AMBIENT atm	298	Bruker AVANCE III HD 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
5	Bruker	AVANCE II	600
1	Bruker	AVANCE III HD	700
2	Bruker	AVANCE III HD	800
3	Bruker	AVANCE NEO	900
4	Bruker	AVANCE III	950

NMR Refinement
Method	Details	Software
molecular dynamics		OPALp

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.6.2	Bruker Biospin
2	chemical shift assignment	Sparky	3.114	Goddard
3	structure calculation	CYANA	3.98	Guntert, Mumenthaler and Wuthrich
4	refinement	OPALp	1.4	Koradi, R., Billeter, M. and Guentert, P
5	peak picking	Sparky	3.114	Goddard

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.